Geriatric patient profile and mortality-associated factors in a population over 80 years with COVID-19 infection: an experience of a university hospital in Bogotá
DOI:
https://doi.org/10.24265/horizmed.2022.v22n4.06Keywords:
Coronavirus Infections, Aged, Mortality, Measures of Association, Exposure, Risk or Outcome, GeriatricsAbstract
Objective: To characterize the geriatric patient profile and identify the mortality-associated factors in a population over 80 years hospitalized with COVID-19 infection in the geriatric ward of a university hospital in the city of Bogotá.
Materials and methods: An analytical observational retrospective cohort study based on chart reviews was conducted. The study included patients over 80 years with confirmed COVID-19 infection from March 1, 2020 to February 28, 2021. The dependent variable was mortality and the independent variables were age, clinical factors, baseline characteristics and paraclinical status.
Results: Two hundred eighty (280) patients with a median age of 84 years, most of whom were overweight, were identified. The most frequent symptom was cough followed by dyspnea. Out of all patients, 60.3 % presented lymphopenia and elevated D-dimer levels (> 1,000 μg/L), and most of them showed typical imaging patterns of COVID-19. Mortality accounted for 41.4 % and was mainly associated with older age, elevated C-reactive protein, activities of daily living impairment, history of major neurocognitive disorder, comorbidity, and dependent and frail patient profiles.
Conclusions: The geriatric population has an increased risk of mortality from COVID-19 infection. The present study
Downloads
References
Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021; 19(3): 141-54.
Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020; 80(6): 639-45.
Peron JPS, Nakaya H. Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE). Clinics. 2020; 75: e1912.
Niu S, Tian S, Lou J, Kang X, Zhang L, Lian H, et al. Clinical characteristics of older patients infected with COVID-19: A descriptive study. Arch Gerontol Geriatr. 2020; 89: 104058.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395(10223): 507-13.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239-42.
Centers for Disease Control and Prevention. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) [Internet]. United States: CDC; 2020. Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm.
Shahid Z, Kalayanamitra R, Mcclafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID‐19 and older adults: what we Know. J Am Geriatr Soc. 2020; 68(5): 926-9.
Chavarro-Carbajal DA, Venegas-Sanabria LC, Correa SMC, Arteaga RCG, Amaya AMP, Cano-Gutiérrez CA. Propuesta de evaluación del anciano con COVID-19 (caso confirmado o sospechoso) basada en la valoración geriátrica integral. Revista ACGG. 2020; 34 (1): 45-58.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20.
Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, et al. Antibody detection and dynamic characteristics in patients with coronavirus disease 2019. Clin Infect Dis. 2020; 71(8): 1930-4.
Baztán JJ, del Molino JP, Alarcón T, Cristóbal ES, Izquierdo G, Manzabeitia I. Índice de Barthel: Instrumento válido para la valoración funcional de pacientes con enfermedad cerebrovascular. Rev Esp Geriatr Gerontol. 1993; 28: 32-40.
Chavarro DA, Heredia RA, Venegas LC, Caicedo SM, Gómez RC, Pardo AM, et al. Escalas de uso frecuente en geriatría. Facultad de Medicina, Instituto de envejecimiento [Internet]. Pontificia Universidad Javeriana. Unidad de Geriatría Centro de Memoria y Cognición. 2020. Disponible en: https://repository.javeriana.edu.co/bitstream/handle/10554/53402/Manual%20de%20escalas%20de%20uso%20freguente%20en%20geriatria%202%20versi%C3%B3n.pdf?sequence=2
Deossa-Restrepo GC, Restrepo-Betancur LF, Velásquez-Vargas JE, Varela Álvarez D. Evaluación nutricional de adultos mayores con el Mini Nutritional Assessment: MNA. Rev Univ Salud. 2016; 18(3):494-504.
Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17: 230.
Castillo FA, Bazaez ND, Huete AG. Radiología en la pandemia COVID-19: Uso actual, recomendaciones para la estructuración del informe radiológico y experiencia de nuestro departamento. Rev Chil Radiol. 2020; 26(3): 88-99.
Trujillo CHS. Sección II. Definiciones operativas de casos de infección por SARS-CoV-2/COVID-19. Consenso Colombiano SARS-CoV-2/COVID-19. Infectio. 2021; 25(4): 10.
Gómez Antúnez M, Míguez AM, Estrada ADB, de La Calle GM, Monge DM, Boixeda R, et al. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2. Int J Chron Obstruct Pulmon Dis. 2021; 15: 3433-45.
Li G, Liu Y, Jing X, Wang Y, Miao M, Tao L, et al. Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study. Aging. 2021; 13(1): 27-60.
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1): 110-8.
Motta JC, Novoa D, Gómez CC, Moreno J, Vargas L, Pérez J, et al. Factores pronósticos en pacientes hospitalizados con diagnóstico de infección por SARS-CoV2 en Bogotá, Colombia. Biomedicina. 2020; 40(Supl. 2): 116-30.
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect. 2020; 80(6): e14-8.
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020; 92(4): 441-7.
Oke J, Heneghan C. Global COVID-19 case fatality rates [Internet]. The Centre for Evidence-Based Medicine; 2020. Disponible en: https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/
Águila-Gordo D, Río JM, Mazoteras-Muñoz V, Negreira-Caamaño M, de la Sierra PNSM, Piqueras-Flores J. Mortality and associated prognostic factors in elderly and very elderly hospitalized patients with respiratory disease COVID-19. Rev Esp Geriatr Gerontol. 2021; 56(5): 259-67.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18): 1775-6.
Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020; 32(8): 1599-608.
Dadras O, SeyedAlinaghi S, Karimi A, Shamsabadi A, Qaderi K, Ramezani M, et al. COVID‐19 mortality and its predictors in the elderly: A systematic review. Health Sci Rep. 2022; 5(3): e657.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
